DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $496,493,750 | -0.3% | 2,001,184 | -3.6% | 0.21% | +3.9% |
| Q2 2023 | $498,134,160 | -9.0% | 2,075,559 | -4.5% | 0.20% | -13.6% |
| Q1 2023 | $547,669,310 | -18.3% | 2,172,946 | -13.9% | 0.24% | -22.2% |
| Q4 2022 | $670,164,532 | -3.5% | 2,524,921 | -6.1% | 0.30% | -10.1% |
| Q3 2022 | $694,479,000 | -4.6% | 2,688,757 | -6.4% | 0.34% | +0.9% |
| Q2 2022 | $728,219,000 | -4.7% | 2,872,434 | +10.3% | 0.33% | +12.9% |
| Q1 2022 | $764,064,000 | -6.0% | 2,604,792 | +5.5% | 0.30% | +2.8% |
| Q4 2021 | $812,626,000 | +8.6% | 2,469,914 | +0.5% | 0.29% | -2.7% |
| Q3 2021 | $748,116,000 | +14.8% | 2,457,350 | +1.2% | 0.30% | +13.0% |
| Q2 2021 | $651,387,000 | +16.3% | 2,427,289 | -2.4% | 0.26% | +6.1% |
| Q1 2021 | $559,979,000 | +25.4% | 2,487,911 | +23.7% | 0.25% | +16.6% |
| Q4 2020 | $446,702,000 | +27.1% | 2,010,905 | +23.2% | 0.21% | +11.6% |
| Q3 2020 | $351,374,000 | +27.4% | 1,631,793 | +4.6% | 0.19% | +16.7% |
| Q2 2020 | $275,859,000 | +22.8% | 1,560,025 | -3.9% | 0.16% | +0.6% |
| Q1 2020 | $224,628,000 | -14.5% | 1,622,920 | -5.2% | 0.16% | +8.1% |
| Q4 2019 | $262,731,000 | +5.3% | 1,711,823 | -0.9% | 0.15% | -3.9% |
| Q3 2019 | $249,599,000 | +1.7% | 1,728,165 | +0.7% | 0.16% | +2.0% |
| Q2 2019 | $245,339,000 | +7.8% | 1,716,619 | -0.4% | 0.15% | +2.7% |
| Q1 2019 | $227,501,000 | +28.2% | 1,723,233 | +0.1% | 0.15% | +12.1% |
| Q4 2018 | $177,506,000 | -10.3% | 1,721,351 | -5.5% | 0.13% | +2.3% |
| Q3 2018 | $197,968,000 | +11.2% | 1,821,905 | +1.0% | 0.13% | +4.0% |
| Q2 2018 | $178,005,000 | -0.5% | 1,803,857 | -1.3% | 0.12% | -3.9% |
| Q1 2018 | $178,913,000 | -20.1% | 1,827,318 | -24.2% | 0.13% | -19.4% |
| Q4 2017 | $223,869,000 | -15.9% | 2,411,862 | -22.3% | 0.16% | -19.6% |
| Q3 2017 | $266,221,000 | -21.7% | 3,103,537 | -23.0% | 0.20% | -24.3% |
| Q2 2017 | $340,082,000 | -14.1% | 4,029,885 | -12.9% | 0.26% | -16.5% |
| Q1 2017 | $395,729,000 | +1.4% | 4,626,781 | -7.7% | 0.32% | -3.1% |
| Q4 2016 | $390,230,000 | +25.5% | 5,013,234 | +26.4% | 0.32% | +24.0% |
| Q3 2016 | $310,981,000 | -38.2% | 3,967,101 | -20.4% | 0.26% | -39.5% |
| Q2 2016 | $503,262,000 | -5.0% | 4,982,794 | -10.8% | 0.43% | -3.8% |
| Q1 2016 | $529,878,000 | -12.9% | 5,585,894 | -14.7% | 0.45% | -13.1% |
| Q4 2015 | $608,334,000 | +5.6% | 6,549,681 | -3.1% | 0.52% | +4.6% |
| Q3 2015 | $576,189,000 | +21.2% | 6,761,991 | +21.8% | 0.50% | +26.0% |
| Q2 2015 | $475,330,000 | +0.4% | 5,553,575 | -0.4% | 0.39% | +2.3% |
| Q1 2015 | $473,405,000 | -8.3% | 5,576,032 | -7.4% | 0.38% | -10.5% |
| Q4 2014 | $516,078,000 | +24.8% | 6,021,215 | +10.6% | 0.43% | +23.3% |
| Q3 2014 | $413,559,000 | -18.5% | 5,442,993 | -15.5% | 0.35% | -18.5% |
| Q2 2014 | $507,128,000 | -3.9% | 6,441,355 | -8.4% | 0.43% | -6.4% |
| Q1 2014 | $527,682,000 | -24.5% | 7,035,761 | -22.3% | 0.46% | -27.0% |
| Q4 2013 | $699,124,000 | +14.5% | 9,056,009 | +2.8% | 0.62% | +3.6% |
| Q3 2013 | $610,687,000 | +22.8% | 8,809,675 | +12.2% | 0.60% | +14.2% |
| Q2 2013 | $497,181,000 | – | 7,854,360 | – | 0.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |